For seventh day, Nagaland reports more Covid-19 recoveries than fresh cases

The recovery rate among patients in the state has gone up to 79.88 per cent from 79.20 per cent on Friday.

Covid-19 vaccine, Coronavirus
Almost 9 million doses of Covaxin are committed by the manufacturer in June.
Press Trust of India Kohima
2 min read Last Updated : Jun 13 2021 | 5:27 AM IST

Nagaland for the seventhconsecutive day on Saturday reported more COVID-19 recoveries than fresh cases as 235 patients recuperated from the disease and 96 new infections pushed the tally to 23,562, a health department official said.

The recovery rate among the COVID-19 patients in the state has gone up to 79.88 per cent from 79.20 per cent on Friday.

As many as 18,822 people have recovered from the infection in the northeastern state.

"At least 96 positive cases detected today - 38 Kohima, 26 Dimapur, 20 Mokokchung, 4 each in Tuensang and Zunheboto, 2 each in Mon and Phek districts," State Nodal Officer for Integrated Disease Surveillance Project Dr Nyanthung Kikon said in the daily COVID-19 bulletin.

Nagaland now has 3,633 active COVID-19 cases, he said. Demise of three COVID-19 patients in Dimapur district increased the death toll in the state to 448, of which 14 are related to other diseases, he said.

Altogether, 659 COVID-19 patients have migrated to other states, he said.

So far, 2,06,708 samples have been tested for COVID- 19 in Nagaland, Dr Kikon said.

As of Friday, 2,80,865 people have been inoculated in the state, including 54,690 who have received the second dose, State Immunisation Officer Dr Ritu Thurr said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jun 13 2021 | 5:27 AM IST

Next Story